BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29976255)

  • 1. Ablation of tau causes an olfactory deficit in a murine model of Parkinson's disease.
    Beauchamp LC; Chan J; Hung LW; Padman BS; Vella LJ; Liu XM; Coleman B; Bush AI; Lazarou M; Hill AF; Jacobson L; Barnham KJ
    Acta Neuropathol Commun; 2018 Jul; 6(1):57. PubMed ID: 29976255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
    Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
    Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.
    Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P
    Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein.
    Zhang S; Xiao Q; Le W
    PLoS One; 2015; 10(3):e0119928. PubMed ID: 25799501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ventral glomerular deficit in Parkinson's disease revealed by whole olfactory bulb reconstruction.
    Zapiec B; Dieriks BV; Tan S; Faull RLM; Mombaerts P; Curtis MA
    Brain; 2017 Oct; 140(10):2722-2736. PubMed ID: 28969383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
    Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
    Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible dopaminergic glutathione depletion in an α-synuclein transgenic mouse model results in age-related olfactory dysfunction.
    Kim YH; Lussier S; Rane A; Choi SW; Andersen JK
    Neuroscience; 2011 Jan; 172():379-86. PubMed ID: 21055449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.
    Petit GH; Berkovich E; Hickery M; Kallunki P; Fog K; Fitzer-Attas C; Brundin P
    PLoS One; 2013; 8(4):e60691. PubMed ID: 23573275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson's disease: cell types involved.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Mohedano-Moriano A; Fradejas N; Calvo S; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
    Mov Disord; 2010 Aug; 25(11):1701-7. PubMed ID: 20574962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced cerebral blood flow in an
    Biju KC; Shen Q; Hernandez ET; Mader MJ; Clark RA
    J Cereb Blood Flow Metab; 2020 Dec; 40(12):2441-2453. PubMed ID: 31856640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein.
    Fleming SM; Tetreault NA; Mulligan CK; Hutson CB; Masliah E; Chesselet MF
    Eur J Neurosci; 2008 Jul; 28(2):247-56. PubMed ID: 18702696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.
    Doorn KJ; Goudriaan A; Blits-Huizinga C; Bol JG; Rozemuller AJ; Hoogland PV; Lucassen PJ; Drukarch B; van de Berg WD; van Dam AM
    Brain Pathol; 2014 Mar; 24(2):152-65. PubMed ID: 24033473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein Pathology and Reduced Neurogenesis in the Olfactory System Affect Olfaction in a Mouse Model of Parkinson's Disease.
    Martin-Lopez E; Vidyadhara DJ; Liberia T; Meller SJ; Harmon LE; Hsu RM; Spence N; Brennan B; Han K; Yücel B; Chandra SS; Greer CA
    J Neurosci; 2023 Feb; 43(6):1051-1071. PubMed ID: 36596700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology.
    Herman S; Djaldetti R; Mollenhauer B; Offen D
    Brain; 2023 Jan; 146(1):209-224. PubMed ID: 35881523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.
    Sharma M; Kaur J; Rakshe S; Sharma N; Khunt D; Khairnar A
    Neurotox Res; 2022 Feb; 40(1):215-229. PubMed ID: 34817799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein in the olfactory system of a mouse model of Parkinson's disease: correlation with olfactory projections.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
    Brain Struct Funct; 2012 Apr; 217(2):447-58. PubMed ID: 21928152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
    Brain Struct Funct; 2014 Sep; 219(5):1513-26. PubMed ID: 24135772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.